1. BOUCK Z., SCHEIM A. I., GOMES T., LING V., CAUDARELLA A., WERB D. (2022): Evaluating Interventions to Facilitate Opioid Agonist Treatment Access among People Who Inject Drugs in Toronto, Ontario During Covid-19 Pandemic Restrictions. Int J Drug Policy. 104: 103680-103680. https://doi.org/10.1016/j.drugpo.2022.103680
2. BROTHERS S., VIERA A., HEIMER R. (2021): Changes in Methadone Program Practices and Fatal Methadone Overdose Rates in Connecticut During Covid-19. J Subst Abuse Treat. 131: 108449-108449. https://doi.org/10.1016/j.jsat.2021.108449
3. CAGLIONI M., RAGONA A., MAREMMANI A. G. I., SILVIA C., CERNIGLIA L. (2023): The Impact of Covid-19 Pandemic on Pregnant Women with Substance Use Disorder (Sud): A Narrative Review. Heroin Addict Relat Clin Probl. 25(2): 13-21. https://www.heroinaddictionrelatedclinicalproblems.org/article.php?id=4185
4. CROWLEY D., CULLEN W. (2021): Caring for Opioid Drug Users During the Covid-19 Pandemic – a Commentary on the Irish Experience Heroin Addict Relat Clin Probl. 23(3): 77-81. https://www.heroinaddictionrelatedclinicalproblems.org/article.php?id=4262
5. FLORES C., RIAZ U. (2023): Maternal Methadone Split Dosing in Pregnancy. Heroin Addict Relat Clin Probl. 25(2): 23-28. https://www.heroinaddictionrelatedclinicalproblems.org/article.php?id=4186